Jim Cramer Looked At These 23 Stocks Recently

Page 20 of 22

3. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Number of Hedge Fund Holders: 68

Commenting on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Cramer said:

“Vertex Pharma comes in second. I don’t give you that enough because they’ve got this terrific new opioid non-habit forming painkiller.”

Vertex (NASDAQ:VRTX) specializes in creating and promoting treatments for cystic fibrosis (CF) and is advancing a portfolio of therapies currently in clinical trials for various other conditions. On March 14, Cramer remarked, “Vertex has got revolutionary anti pain drug.”

On February 10, Vertex (NASDAQ:VRTX) reported a 12% increase in product revenue for 2024, which was $11.02 billion and it was largely driven by the strong performance of its cystic fibrosis treatments, TRIKAFTA/KAFTRIO. For 2025, the company has projected total revenue between $11.75 billion and $12.0 billion.

Page 20 of 22